← FDA Drug Approvals (Drugs@FDA)

SOLIFENACIN SUCCINATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: WATSON LABS INC · Approved 2019-05-20

Drug application

FDA Application #

ANDA202551

Application type

Abbreviated New Drug Application (Generic)

Brand name

SOLIFENACIN SUCCINATE

Generic name

SOLIFENACIN SUCCINATE

Active ingredients

SOLIFENACIN SUCCINATE

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

WATSON LABS INC

Manufacturer

Actavis Pharma, Inc.

First approval

2019-05-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown